Morgan Stanley On What 'Should Be Rewarded' At Gilead By: Benzinga via Benzinga May 01, 2015 at 07:14 AM EDT In a report published Friday, Morgan Stanley analysts maintained an Overweight rating on Gilead Sciences Inc (NASDAQ: GILD), with a ... Read More >> Related Stocks: Astrazeneca Plc ADR Gilead Sciences